237 related articles for article (PubMed ID: 29977206)
1. Interplay of miRNAs and Canonical Wnt Signaling Pathway in Hepatocellular Carcinoma.
Nie X; Liu Y; Chen WD; Wang YD
Front Pharmacol; 2018; 9():657. PubMed ID: 29977206
[TBL] [Abstract][Full Text] [Related]
2. Interplay of Wnt β-catenin pathway and miRNAs in HBV pathogenesis leading to HCC.
Rana MA; Ijaz B; Daud M; Tariq S; Nadeem T; Husnain T
Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):373-386. PubMed ID: 30377095
[TBL] [Abstract][Full Text] [Related]
3. Atypical regulators of Wnt/β-catenin signaling as potential therapeutic targets in Hepatocellular Carcinoma.
Chen J; Rajasekaran M; Hui KM
Exp Biol Med (Maywood); 2017 Jun; 242(11):1142-1149. PubMed ID: 28429652
[TBL] [Abstract][Full Text] [Related]
4. Aberrant regulation of Wnt signaling in hepatocellular carcinoma.
Liu LJ; Xie SX; Chen YT; Xue JL; Zhang CJ; Zhu F
World J Gastroenterol; 2016 Sep; 22(33):7486-99. PubMed ID: 27672271
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
Quan H; Li B; Yang J
Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-194 inhibits cell invasion and migration in hepatocellular carcinoma through PRC1-mediated inhibition of Wnt/β-catenin signaling pathway.
Tang H; Zhao H; Yu ZY; Feng X; Fu BS; Qiu CH; Zhang JW
Dig Liver Dis; 2019 Sep; 51(9):1314-1322. PubMed ID: 30948333
[TBL] [Abstract][Full Text] [Related]
7. The crosstalk between microRNAs and the Wnt/β-catenin signaling pathway in cancer.
Peng Y; Zhang X; Feng X; Fan X; Jin Z
Oncotarget; 2017 Feb; 8(8):14089-14106. PubMed ID: 27793042
[TBL] [Abstract][Full Text] [Related]
8. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
Cao F; Yin LX
Exp Mol Pathol; 2019 Feb; 106():34-43. PubMed ID: 30539797
[TBL] [Abstract][Full Text] [Related]
9. [Role of Wnt/β-catenin signaling pathway in promoting tumorigenesis of hepatocellular carcinoma].
Xie L; Jiang H; Wu F
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jun; 34(6):913-7. PubMed ID: 24968856
[TBL] [Abstract][Full Text] [Related]
10. Wnt/Frizzled signaling in hepatocellular carcinoma.
Lee HC; Kim M; Wands JR
Front Biosci; 2006 May; 11():1901-15. PubMed ID: 16368566
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of HDAC6 suppresses tumor cell proliferation and metastasis by inhibition of the canonical Wnt/β-catenin signaling pathway in hepatocellular carcinoma.
Yin Z; Xu W; Xu H; Zheng J; Gu Y
Oncol Lett; 2018 Dec; 16(6):7082-7090. PubMed ID: 30546442
[TBL] [Abstract][Full Text] [Related]
12. NTS/NTR1 co-expression enhances epithelial-to-mesenchymal transition and promotes tumor metastasis by activating the Wnt/β-catenin signaling pathway in hepatocellular carcinoma.
Ye Y; Long X; Zhang L; Chen J; Liu P; Li H; Wei F; Yu W; Ren X; Yu J
Oncotarget; 2016 Oct; 7(43):70303-70322. PubMed ID: 27611941
[TBL] [Abstract][Full Text] [Related]
13. CircZFR promotes hepatocellular carcinoma progression through regulating miR-3619-5p/CTNNB1 axis and activating Wnt/β-catenin pathway.
Tan A; Li Q; Chen L
Arch Biochem Biophys; 2019 Jan; 661():196-202. PubMed ID: 30468709
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of miR-432 activates Wnt/β-catenin signaling and promotes human hepatocellular carcinoma proliferation.
Jiang N; Chen WJ; Zhang JW; Xu C; Zeng XC; Zhang T; Li Y; Wang GY
Oncotarget; 2015 Apr; 6(10):7866-79. PubMed ID: 25797263
[TBL] [Abstract][Full Text] [Related]
15. The Wnt/β-catenin pathway as a therapeutic target in human hepatocellular carcinoma.
Dahmani R; Just PA; Perret C
Clin Res Hepatol Gastroenterol; 2011 Nov; 35(11):709-13. PubMed ID: 21778132
[TBL] [Abstract][Full Text] [Related]
16. WNT1 Gene from WNT Signaling Pathway Is a Direct Target of miR-122 in Hepatocellular Carcinoma.
Ahsani Z; Mohammadi-Yeganeh S; Kia V; Karimkhanloo H; Zarghami N; Paryan M
Appl Biochem Biotechnol; 2017 Mar; 181(3):884-897. PubMed ID: 27687586
[TBL] [Abstract][Full Text] [Related]
17. Wnt signaling in liver cancer.
Takigawa Y; Brown AM
Curr Drug Targets; 2008 Nov; 9(11):1013-24. PubMed ID: 18991612
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of miR-610 promotes proliferation and tumorigenicity and activates Wnt/β-catenin signaling in human hepatocellular carcinoma.
Zeng XC; Liu FQ; Yan R; Yi HM; Zhang T; Wang GY; Li Y; Jiang N
Mol Cancer; 2014 Dec; 13():261. PubMed ID: 25491321
[TBL] [Abstract][Full Text] [Related]
19. Distinctive microRNA signature associated of neoplasms with the Wnt/β-catenin signaling pathway.
Sun X; He Y; Huang C; Ma TT; Li J
Cell Signal; 2013 Dec; 25(12):2805-11. PubMed ID: 24041653
[TBL] [Abstract][Full Text] [Related]
20. MiR-342 regulates cell proliferation and apoptosis in hepatocellular carcinoma through Wnt/β-catenin signaling pathway.
Lu C; Jia S; Zhao S; Shao X
Cancer Biomark; 2019; 25(1):115-126. PubMed ID: 31006667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]